Related Experiment Video

Updated: Jun 2, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Congenital adrenal hyperplasia: an update in children

Christine M Trapp1, Phyllis W Speiser, Sharon E Oberfield

  • 1Division of Pediatric Endocrinology, Children's Hospital of New York-Presbyterian, Columbia University College of Physicians and Surgeons, New York 10032, USA.

Current Opinion in Endocrinology, Diabetes, and Obesity
|April 16, 2011
PubMed

Insights

Recent advances improve early diagnosis of congenital adrenal hyperplasia (CAH) in newborns. However, optimal treatment and management strategies for children with CAH, particularly 21-hydroxylase deficiency, require further research.

Area of Science:

  • Pediatric Endocrinology
  • Genetics
  • Metabolic Disorders

Background:

  • Congenital adrenal hyperplasia (CAH) comprises genetic disorders affecting cortisol synthesis.
  • 21-hydroxylase deficiency is the most common cause of CAH in children.
  • Current management and treatment protocols for pediatric CAH remain debated.

Purpose of the Study:

  • To review recent advancements in neonatal screening for CAH.
  • To present current recommendations for managing classic and nonclassic 21-hydroxylase deficiency in children.
  • To address ongoing debates in pediatric CAH treatment.

Main Methods:

  • Literature review of recent studies on CAH diagnosis and treatment.
  • Analysis of advancements in neonatal screening protocols.
  • Synthesis of current therapeutic recommendations for 21-hydroxylase deficiency.

Main Results:

  • Neonatal screening for CAH has significantly improved, enabling earlier diagnosis and reducing associated morbidity and mortality.
  • Recent research offers new insights into refining treatment and management strategies for children with CAH.
  • Progress has been made in achieving normal growth and development in treated children.

Conclusions:

  • Optimal management and treatment for pediatric CAH are still under investigation.
  • Despite diagnostic and therapeutic progress, further research is needed to fully optimize care for children with CAH.
  • Continued study is essential for improving long-term outcomes in individuals with 21-hydroxylase deficiency.
Abstract

More Related Videos

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...